ArticleThe Journal of clinical endocrinology and metabolism2026
Clinical picture of early-infancy PTH resistance syndromes: is it time to improve diagnostic criteria?
Article in The Journal of clinical endocrinology and metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical picture of early-infancy PTH resistance syndromes: is it time to improve diagnostic criteria?The Journal of clinical endocrinology and metabolism · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
contextClinical presentation of inactivating parathyroid hormone (PTH)/PTH-related protein (PTHrP) signaling disorders (iPPSDs, historically pseudohypoparathyroidism [PHP]) exhibits pronounced age-dependence. Indeed, main features, including PTH resistance and brachydactyly (BD), develop during late childhood, while other features (ectopic ossifications, obesity, and hypothyroidism) are most prevalent in toddlers. The latter are included among minor diagnostic criteria; therefore, a substantial diagnostic delay has been reported.
objectiveThe aim of this work is to describe the early natural history of a large cohort of iPPSD/PHP patients to improve diagnosis, with the final goal of proposing new diagnostic criteria for early infancy and reducing diagnostic delay.
methodsWe included 117 patients regularly followed up at 2 European endocrinology tertiary centers, and we retrospectively collected data on the age of onset of main clinical and hormonal features.
resultsIn our cohort the median age at diagnosis was 5.9 years. Age of onset of PTH resistance and BD, major criteria for diagnosis, was significantly different from that of both thyrotropin (TSH) resistance and obesity (median age 6.1, 5.8, 1.85, and 2 years, respectively). Minor diagnostic criteria were more represented than major criteria in children before age 2 years (P = .002). Indeed, in 64% of patients before age 2 years none of the major criteria were observed; conversely, 71% had already developed at least one minor criterion. In particular, 20% had developed TSH resistance and obesity.
conclusionThe clinical picture of iPPSD/PHP in early infancy differs from that of mid-late infancy and adults, thus current diagnostic criteria may not be appropriate for children. We suggest that the combination of early-onset obesity and elevated TSH should raise suspicion and trigger genetic screening before age 2 years.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.